Total debt has held in a narrow $4.2B to $4.7B band with debt-to-equity of 0.93 in 2026Q3 and a current ratio of only 0.88, while goodwill fell from $1.7B to $1.1B, signaling a contracting and leveraged capital structure.
Clarivate Plc (CLVT) balance sheet — 9-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 |
|---|
| Total Current Assets | 1.23B | 1.31B | 1.24B | 1.46B | 1.4B | 1.64B | 1.15B | 493.08M | 408.61M | 443.91M |
| Cash & Short-Term Investments | 257M | 329.2M | 295.2M | 370.7M | 348.8M | 587.61M | 257.73M | 76.13M | 25.57M | 53.19M |
| Cash Only | 257M | 329.2M | 295.2M | 370.7M | 348.8M | 587.61M | 257.73M | 76.13M | 25.57M | 53.19M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 747.4M | 821.7M | 798.3M | 908.3M | 872.1M | 906.43M | 737.73M | 333.86M | 331.3M | 317.81M |
| Days Sales Outstanding | 131.76 | 122.16 | 113.97 | 126.11 | 119.68 | 176.27 | 214.71 | 125.07 | 124.86 | 126.41 |
| Inventory | 0 | 0 | 0 | 0 | 97.4M | 0 | 0 | 0 | 31.03M | 52.76M |
| Days Inventory Outstanding | - | - | - | - | 37.27 | - | - | - | 28.56 | 48.85 |
| Other Current Assets | 132.2M | 64.9M | 65.2M | 94.7M | 76.9M | 66.65M | 93.83M | 42.38M | 31.13M | 44.52M |
| Total Non-Current Assets | 9.14B | 9.76B | 10.25B | 11.24B | 12.55B | 18.55B | 13.64B | 3.3B | 3.3B | 3.56B |
| Property, Plant & Equipment | 83.3M | 99.3M | 107.1M | 106.8M | 113.4M | 169.88M | 168.62M | 103.49M | 20.64M | 23.01M |
| Fixed Asset Turnover | 24.94x | 24.73x | 23.87x | 24.61x | 23.46x | 11.05x | 7.44x | 9.41x | 46.92x | 39.88x |
| Goodwill | 1.09B | 1.57B | 1.57B | 2.02B | 2.88B | 7.9B | 6.04B | 1.33B | 1.28B | 1.31B |
| Intangible Assets | 7.16B | 8.01B | 8.44B | 9.01B | 9.44B | 10.39B | 7.37B | 1.83B | 1.96B | 2.16B |
| Long-Term Investments | 34.1M | 1.8M | 14.7M | 17.7M | 47.2M | 1.96M | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 789M | 66.3M | 67.5M | 43.1M | 50.7M | 48.75M | 31.33M | 18.63M | 26.56M | 60.03M |
| Total Assets | 10.37B | 11.07B | 11.49B | 12.71B | 13.94B | 20.18B | 14.79B | 3.79B | 3.71B | 4.01B |
| Asset Turnover | 0.21x | 0.22x | 0.22x | 0.21x | 0.19x | 0.09x | 0.08x | 0.26x | 0.26x | 0.23x |
| Asset Growth % | -24.42% | -3.66% | -9.57% | -8.88% | -30.91% | 36.46% | 290.11% | 2.2% | -7.38% | - |
| Total Current Liabilities | 1.4B | 1.57B | 1.43B | 1.6B | 1.56B | 1.9B | 1.42B | 651M | 643.71M | 661.07M |
| Accounts Payable | 117.2M | 150.6M | 124.5M | 144.1M | 101.4M | 129.22M | 82.04M | 26.46M | 38.42M | 60.76M |
| Days Payables Outstanding | 70.38 | 65.94 | 52.28 | 58.03 | 38.8 | 75.33 | 68.24 | 27.44 | 35.37 | 56.26 |
| Short-Term Debt | 1.6M | 101.5M | 20.6M | 24.4M | 0 | 62.75M | 28.6M | 9M | 60.34M | 45.34M |
| Deferred Revenue (Current) | 3.6B | 941.4M | 943.9M | 983.1M | 947.5M | 1.03B | 707.32M | 407.32M | 391.1M | 361.26M |
| Other Current Liabilities | 144.5M | 146.7M | -20.6M | 321.9M | 353.1M | 348.01M | 57.75M | 26.87M | 0 | 0 |
| Current Ratio | 0.88x | 0.84x | 0.87x | 0.91x | 0.89x | 0.86x | 0.81x | 0.76x | 0.63x | 0.67x |
| Quick Ratio | 0.88x | 0.84x | 0.87x | 0.91x | 0.83x | 0.86x | 0.81x | 0.76x | 0.59x | 0.59x |
| Cash Conversion Cycle | 61.39 | - | - | - | 118.15 | - | - | - | 118.06 | 119 |
| Total Non-Current Liabilities | 4.45B | 4.66B | 4.92B | 5.11B | 5.57B | 6.36B | 4.33B | 1.89B | 2.02B | 2.06B |
| Long-Term Debt | 4.14B | 4.32B | 4.52B | 4.72B | 4.97B | 5.46B | 3.46B | 1.63B | 1.93B | 1.97B |
| Capital Lease Obligations | 130.7M | 37.9M | 53.2M | 63.2M | 72.9M | 93.95M | 104.32M | 64.19M | 0 | 0 |
| Deferred Tax Liabilities | 810M | 212.1M | 273.3M | 249.6M | 316.1M | 380.06M | 367M | 48.55M | 43.23M | 51.79M |
| Other Non-Current Liabilities | 69.3M | 86.2M | 55.9M | 41.9M | 171.4M | 370.59M | 362.2M | 130.7M | 24.84M | 22.61M |
| Total Liabilities | 5.85B | 6.23B | 6.35B | 6.71B | 7.13B | 8.26B | 5.76B | 2.54B | 2.66B | 2.72B |
| Total Debt | 4.18B | 4.48B | 4.59B | 4.81B | 5.07B | 5.61B | 3.63B | 1.72B | 1.99B | 2.01B |
| Net Debt | 3.93B | 4.15B | 4.3B | 4.44B | 4.72B | 5.03B | 3.37B | 1.65B | 1.96B | 1.96B |
| Debt / Equity | 0.93x | 0.92x | 0.89x | 0.80x | 0.74x | 0.47x | 0.40x | 1.38x | 1.89x | 1.57x |
| Debt / EBITDA | 6.61x | 5.41x | 10.17x | - | - | 12.45x | 13.59x | 14.60x | 15.14x | 24.72x |
| Net Debt / EBITDA | 6.21x | 5.01x | 9.52x | - | - | 11.15x | 12.62x | 13.96x | 14.94x | 24.07x |
| Interest Coverage | -0.36x | 0.65x | -0.95x | -2.45x | -13.76x | -0.02x | -2.16x | -0.58x | -0.81x | -1.06x |
| Total Equity | 4.51B | 4.84B | 5.14B | 5.99B | 6.81B | 11.93B | 9.03B | 1.25B | 1.05B | 1.29B |
| Equity Growth % | -27.59% | -5.76% | -14.24% | -12.04% | -42.88% | 32% | 623.59% | 18.85% | -18.31% | - |
| Book Value per Share | 7.06 | 7.19 | 7.41 | 8.92 | 10.04 | 18.61 | 21.08 | 4.56 | 3.44 | 4.21 |
| Total Shareholders' Equity | 4.51B | 4.84B | 5.14B | 5.99B | 6.81B | 11.93B | 9.03B | 1.25B | 1.05B | 1.29B |
| Common Stock | 12.83B | 12.81B | 12.98B | 11.74B | 11.74B | 11.83B | 9.99B | 2.14B | 16K | 16K |
| Retained Earnings | -7.9B | -7.51B | -7.31B | -6.65B | -5.66B | -1.6B | -1.25B | -890.89M | -632.26M | -390.1M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | -16.96M | -196.04M | 0 | 0 | 0 |
| Accumulated OCI | -407.2M | -453.1M | -526.3M | -495.3M | -665.9M | 326.75M | 492.38M | -4.88M | 5.36M | 13.98M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying CLVT stock.
As of 2025, Clarivate Plc (CLVT) had total assets of $11.07B including $1.31B in current assets.
Clarivate Plc (CLVT) carries total debt of $4.48B, offset by $329.2M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Clarivate Plc (CLVT) has total shareholders' equity (book value) of $4.84B ($7.19 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Clarivate Plc (CLVT) reported a current ratio of 0.84x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Leverage against shrinking equity base
Metrics are mathematically derived from official filings.
Deleveraging Offset by Shrinking Equity
Based on reported figures, Clarivate's total assets fell from $12.1B in 2024Q2 to $10.4B in 2026Q3, while equity declined from $5.6B to $4.5B, indicating the balance sheet is contracting on both sides.
The reduction in total assets is largely driven by declining goodwill, which dropped from $1.7B to $1.1B, suggesting impairments or write-downs rather than purely operational asset rotation. Because equity has contracted alongside assets, the modest improvement in debt-to-equity to 0.93 does not reflect a stronger capital base but rather a smaller one. Investors should monitor whether further impairment charges continue to erode the equity cushion.
Debt Stable but Leverage Elevated
According to reported quarterly data, total debt has held in a narrow $4.2B to $4.7B band, with the debt-to-equity ratio remaining between 0.84 and 0.94, a level that leaves limited room for earnings deterioration.
Total debt has been reduced modestly from $4.7B to $4.2B over the ten-quarter window, which may indicate active paydown, though the magnitude is small relative to the overall leverage burden. With revenue contracting and net losses recurring, the ability to service this debt from earnings appears constrained. Refinancing risk and the sustainability of cash flow to cover interest obligations warrant further investigation.
Thin Liquidity Against Heavy Obligations
Based on Clarivate's reported figures, the current ratio has stayed below 0.91 across the ten quarters, while cash ranged between $218M and $389M against total liabilities of roughly $5.9B to $6.5B.
A current ratio under 1.0 combined with modest cash balances suggests a limited near-term liquidity buffer relative to the size of the liability base. Operating cash flow has helped sustain cash levels, but the decline in OCF creates pressure on this coverage over time. The liquidity position appears adequate only so long as operating cash generation holds, and investors should monitor cash balances against scheduled obligations.
Deferred Revenue Declining Signals Softer Visibility
As reported in financial statements, deferred revenue fell from $996M in 2025Q1 to $780M in 2026Q3, a decline of roughly 22%, which tracks the broader contraction in quarterly revenue.
Deferred revenue is a forward indicator of contracted, unrecognized sales, and its sustained decline suggests reduced future revenue visibility rather than a timing effect alone. The trend is consistent with the revenue contraction observed in the income statement, reinforcing the view that the top line may continue to soften. Investors should monitor whether deferred revenue stabilizes, as continued erosion would point to weakening renewal or new-bookings momentum.
Goodwill Impairment Could Distort Equity Trend
Based on reported figures, goodwill fell roughly $0.6B from $1.7B to $1.1B, and further write-downs could erode the remaining equity base faster than headline leverage ratios suggest.
Headline debt-to-equity improvement partly reflects a shrinking denominator rather than debt reduction alone, which can make the leverage profile look more stable than the underlying capital position warrants. If remaining goodwill is impaired further, equity could fall toward levels that would materially raise leverage even with flat debt. Investors should treat the goodwill balance as a key sensitivity in any assessment of the balance sheet's resilience.